Search

Search Results

• Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

  E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova

  142-151

  01.04.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• Pathogenesis of Respiratory Distress in Acute Leukemia with Hyperleukocytosis

  Regina Ramilevna Tukhvatullina, N.V. Matinyan, T.T. Valiev, O.A. Ignatenko, N.V. Kokosadze, S.R. Varfolomeeva

  372-379

  01.10.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• A Rare Case of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

  Anastasiya Gennadevna Kolgotina, L.A. Kramynin, I.V. Ishmatova, L.V. Filatova, P.A. Sapronov, M.V. Grinkevich, A.L. Muravtseva, I.S. Zyuzgin

  277-285

  01.07.2025

• Functional Cure as a New Concept of Therapy for Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  105-120

  01.04.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure

  Ekaterina Alekseevna Karimova, E.I. Zhelnova, E.A. Baryakh, E.Yu. Grishina, E.N. Zotina, D.E. Gagloeva, V.N. Yakimets, O.L. Kochneva, E.N. Misyurina

  171-176

  01.04.2025

• The Efficacy of Bortezomib, Lenalidomide, and Dexamethasone Combination as Induction Therapy in Patients with Multiple Myeloma Complicated by the End-Stage Renal Disease

  Sergei Vyacheslavovich Semochkin, E.I. Zhelnova, V.I. Kazey, A.V. Cherkasova, A.G. Nikiforova, N.F. Frolova, E.A. Baryakh, K.V. Yatskov, E.A. Karimova, O.N. Kotenko, E.N. Misyurina

  360-369

  01.10.2024

• Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

  Yana Konstantinovna Mangasarova, R.R. Abdurashidova, A.U. Magomedova, O.V. Margolin, E.S. Nesterova, L.G. Gorenkova, M.O. Bagova, E.A. Fastova, D.S. Belkina, A.M. Kovrigina, N.G. Gabeeva, D.A. Koroleva, S.K. Kravchenko, Yu.A. Chabaeva, E.E. Zvonkov

  335-346

  01.10.2024

• KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

  Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva

  256-265

  01.07.2024

• Treatment of Diffuse Large B-Cell Lymphoma at the Moscow City Clinical Hospital No. 52: A Retrospective Clinical Trial Based on the Single-Center Experience and Analysis of Data from Its In-House Registry

  Marat Albertovich Mingalimov, E.A. Baryakh, Yu.Yu. Polyakov, E.N. Misyurina, E.I. Zhelnova, K.V. Yatskov, A.B. Makeshova, T.N. Tolstykh, TS Chudnova, D.D. Ivanova, O.L. Kochneva, I.V. Samsonova, M.A. Lysenko

  11-17

  17.05.2024

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• The Role of Autologous Hematopoietic Stem Cell Transplantation in the Therapy of Systemic AL Amyloidosis

  Olga Vladislavovna Pirogova, O.V. Kudyasheva, A.G. Smirnova, V.V. Porunova, S.V. Tolstova, K.R. Kalimulina, M.V. Chernous, Yu.Yu. Vlasova, I.S. Moiseev, V.A. Dobronravov, A.D. Kulagin

  128-136

  03.03.2023

• The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

  Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova, E.A. Belyakova

  377-387

  01.10.2022

• The Importance of Complementary Immunological Markers in the Diagnosis of Minimal Residual Disease in Multiple Myeloma

  E.E. Tolstykh, O.S. Chuvadar, A.A. Semenova, N.A. Kupryshina, O.P. Kolbatskaya, Yu.I. Klyuchagina, O.A. Kolomeitsev, G.S. Tumyan, Nikolai Nikolaevich Tupitsyn

  388-395

  01.10.2022

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma with Renal Impairment

  Maiya Valerevna Firsova, L.P. Mendeleeva, M.V. Solov’ev, D.A. Mironova, L.A. Kuzmina, V.G. Savchenko

  97-106

  01.01.2022

• Current State of Diagnosis and Treatment of Acute Myeloid Leukemias in Adult Patients in the Republic of Kazakhstan

  A.A. Klodzinskii, I.A. Pivovarova, L.G. Turgunova, Aimzhan Zharkynovna Anafina, A.V. Zinchenko

  69-75

  01.01.2022

• Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

  Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva

  321-332

  01.07.2021

• Use of Blinatumomab in Acute Lymphoblastic Leukemia in Municipal Healthcare: A Case Report

  Vasilii Anatolevich Shuvaev, O.V. Ushakova, E.I. Mullo, T.V. Tolstykh, N.Z. Triputen

  198-203

  01.04.2021

• Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

  Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  289-296

  01.07.2019

• Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

  Oleg Aleksandrovich Shukhov, A.G. Turkina, E.Yu. Chelysheva, A.V. Bykova, A.N. Petrova, G.A. Gusarova, I.S. Nemchenko, A.O. Abdullaev, T.N. Obukhova, A.B. Sudarikov

  194-201

  01.04.2019

• Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

  Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev

  68-72

  01.01.2019

• Factors Associated with Efficient Harvesting and Engraftment of Auto-Transplants in Multiple Myeloma Patients

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, Zh.V. Chubukina, N.Yu. Semenova, I.M. Zapreeva, S.A. Tiranova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev

  32-36

  01.01.2019

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs

  Ol’ga Vladislavovna Pirogova, E.I. Darskaya, V.V. Porunova, O.V. Kudyasheva, A.G. Smirnova, I.S. Moiseev, E.V. Babenko, B.V. Afanas’ev

  187-191

  01.04.2018

• Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, Zh.V. Chubukina, I.M. Zapreeva, S.A. Tiranova, A.V. Sel’tser, N.Yu. Semenova, S.S. Bessmel’tsev, A.V. Chechetkin, S.V. Gritsaev

  192-197

  01.04.2018

• Antibiotic Treatment of Febrile Neutropenia in Patients with Acute Leukemia

  Vladimir Aleksandrovich Okhmat, G.A. Klyasova, E.N. Parovichnikova, V.V. Troitskaya, E.O. Gribanova, V.G. Savchenko

  100-109

  01.01.2018

• Thrombotic and Hemorrhagic Complications in the Treatment of Acute Lymphoblastic Leukemia with L-Asparaginase

  Gennadii Martinovich Galstyan, O.A. Polevodova, A.V. Bazhenov, V.V. Troitskaya, O.A. Gavrilina, D.G. Gitel’zon, A.E. Vasil’ev, E.N. Parovichnikova

  89-99

  01.01.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia

  L.L. Girshova, Irina Garmaevna Budaeva, E.G. Ovsyannikova, S.O. Kuzin, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskii

  485-493

  01.10.2017

• Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

  Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich

  381-389

  01.07.2017

• Evaluation of Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Using EuroFlow Approaches

  Ol’ga Alekseevna Beznos, L.Yu. Grivtsova, A.V. Popa, M.A. Shervashidze, I.N. Serebryakova, O.Yu. Baranova, E.A. Osmanov, N.N. Tupitsyn

  158-168

  01.04.2017

• NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)

  M.A. Frenkel’, O.Yu. Baranova, Alina Sergeevna Antipova, N.A. Kupryshina, N.N. Tupitsyn

  208-217

  01.04.2016

• Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

  Sergei Vasil’evich Gritsaev, I.I. Kostroma, A.A. Kuzyaeva, I.M. Zapreeva, E.V. Litvinskaya, L.V. Stel’mashenko, S.A. Tiranova, I.S. Martynkevich, N.A. Potikhonova, K.M. Abdulkadyrov

  48-53

  01.01.2016

• Acute Myeloid Leukemias: 10-Year Therapy Experience

  Ol’ga Yur’evna Baranova, A.S. Antipova, O.D. Zakharov, N.A. Falaleeva, G.I. Kaletin, A.D. Shirin, G.R. Arakelyan, N.N. Tupitsyn, M.A. Frenkel’, N.A. Kupryshina, T.N. Obukhova, E.V. Domracheva, V.B. Larionova, E.V. Ogorodnikova, E.A. Osmanov

  287-301

  01.07.2015

• Rationale for Maintenance Treatment of Patients with Acute Myeloid Leukemia below 65 Years of Age, According to Data of a Retrospective Analysis of Protocols AML-2000 and AML-2007

  S.V. Semochkin, T.N. Tolstykh, V.V. Lunin, N.K. Khuazheva, A.I. Kostin, S.A. Chernysh, M.E. Pochtar, V.L. Ivanova

  564-572

  01.10.2014

• Multiple myeloma (management of newly diagnosed patients): literature review and our on data. Part II

  S.S. Bessmeltsev

  379-414

  01.10.2013

• Mantle cell lymphoma: program therapy for untreated patients under 65 years

  V.I. Vorobyev, S.K. Kravchenko, E.G. Gemdjian, Yu.Yu. Lorie, A.U. Magomedova, A.L. Melikyan, J.K. Mangasarova, D.S. Mar’yin, E.I. Dubrovin, T.N. Obukhova, S.A. Makhinya, V.A. Zherebtsova, M.A. Vernyuk, N.G. Tyurina, V.G. Savchenko

  274-281

  01.07.2013

• Management of refractory acute lymphoblastic leukemia in children and adolescents: remission re-induction followed by allogeneic hematopoietic stem cell transplantation

  E.V. Semenova, N.V. Stancheva, S.N. Bondarenko, V.N. Vavilov, D.A. Bagge, O.V. Paina, S.V. Razumova, A.S. Borovkova, T.A. Bykova, A.A. Raths, L.S. Zuborovskaya, B.V. Afanasyev

  53-59

  01.01.2013